Photo by Tech Daily on Unsplash
The Common Belief
What if the most important number in a “three undervalued stocks” article is the date printed above it?
That question matters here more than usual. The original write-up behind this topic, credited to AI Fallback, and the cluster of coverage around it are anchored to a specific event: the S&P 500 falling roughly 10% from recent highs in August 2024, on worries about Federal Reserve policy and cooling growth. Anyone reading a recycled version of that list on August 13, 2026 is looking at a snapshot, not a live quote. Every price, ratio and yield below carries its original 2024 date qualifier for exactly that reason — and the first practical move for any reader is to re-pull those figures before acting on them.
The conventional framing is comfortable: markets fall 10%, quality names go on sale, patient buyers get paid. As of August 2024, Bank of America strategists made a version of that case, arguing that corrections of 10% or more are “healthy and normal parts of bull markets” that let disciplined investors add quality names at better valuations. Morgan Stanley equity research went further, calling valuations in defensive corners like healthcare and consumer staples “a gift for long-term investors.” Both are defensible. Neither tells you what actually got cheap, or by how much.
Where It Breaks Down
Start with the internal contradiction in the standard pitch. One widely repeated line holds that 10% corrections happen roughly once a year. But S&P Dow Jones Indices' own drawdown research counts 28 corrections of 10% or more since 1950 — across roughly seven decades, that is closer to one every two and a half years than one a year (S&P Dow Jones Indices). Yahoo Finance framed the August 2024 episode as the fourth 10% pullback since 2020, which fits the faster cadence — but a four-year window that includes a pandemic crash is not the base rate. The reassurance and the primary data are not saying the same thing, and the gap is worth noticing before anyone builds a plan around “this happens every year.”
Photo by Bermix Studio on Unsplash
What Actually Got Cheaper — and What Only Looks It
Here is the part surface coverage tends to skip. According to Federal Reserve Economic Data, the S&P 500 forward price-to-earnings ratio (the index price divided by the profits companies are expected to earn over the next year) sat at 19.48 as of August 2024, down from roughly 21.5x earlier that year. Run the ratio: 19.48 divided by 21.5 is about 0.906, a de-rating of roughly 9.4%.
Now put that next to the price move. The index fell about 10%. Meanwhile, S&P 500 companies were expected to grow earnings 8–10% in 2024. In plain terms: almost the entire decline came from investors paying less for the same expected profits, not from those profits being marked down. That is a meaningfully different animal from an earnings recession, and it is the strongest argument the dip-buyers had.
Chart: Forward P/E multiples as reported for August 2024. Index figures from FRED; the Taiwan Semiconductor multiple as cited by The Motley Fool. Not current pricing.
The discounts were also wildly uneven. Technology led the drawdown at about −12%, consumer discretionary fell roughly 11%, and communication services around 10%. The Motley Fool's specific picks were Taiwan Semiconductor (TSM), Pfizer (PFE) and Realty Income (O), pointing to TSM trading near 15x forward earnings against a historical 20x. That is a 25% discount to its own history — nearly three times the roughly 9.4% de-rating the whole index took. So the honest version of “stocks are cheap” is: a handful of names got genuinely marked down, and the index got modestly re-priced.
The counter-argument deserves airtime, because the sources themselves diverge. Even as The Motley Fool made the semiconductor case, other analysts stayed cautious on chips over a possible demand slowdown in 2025 — meaning that 15x multiple is only cheap if the earnings estimate underneath it holds. A low P/E built on an estimate that later gets cut is not a discount; it is a trap door. The same skepticism applies to the AI complex more broadly: as of August 2024, some AI infrastructure names were down 15–20% from peaks despite strong fundamental growth, which pulled semiconductors, cloud infrastructure and data center REITs to more approachable valuations. Whether that was a sale or a re-rating depended entirely on the durability of the spending behind it.
Then there is the yield problem nobody puts in the headline. Yahoo Finance noted dividend yields on the recommended names ranging from 3.5% to 6%. With 10-year Treasury yields above 4% at the time, a 3.5% dividend was losing to a government bond on income alone — before any price risk. Flip the index multiple for the same comparison: 1 divided by 19.48 is an earnings yield of about 5.1%, roughly a point above that Treasury. A single point of cushion for taking full equity risk is thin, and it explains why elevated yields were competing directly with stock valuations rather than sitting harmlessly in the background.
In Plain Terms: What a 10% Drop Does to $10,000
Say a reader had $10,000 in a broad index fund at the peak. A 10% fall leaves about $9,000. Getting back to $10,000 from there does not require a 10% gain — it requires about 11.1%, because the gain is calculated on the smaller balance. That asymmetry is the whole reason corrections feel worse than the math suggests.
Now the other side. Investors who added during the 2018, 2020 and 2022 pullbacks saw average returns in the 15–25% range over the following 12 months. Applied to that same $9,000, the low end of that band works out to roughly $10,350 and the high end to about $11,250 a year later. Useful context — but the sample is three episodes, all inside one of the strongest equity decades on record. Treat it as a pattern, not a promise.
The VIX (a market gauge of expected volatility, often called the fear index) spiking above 30 during the correction is the emotional read on that same arithmetic. Fear is the price of the discount; you do not get one without the other. This is the same behavioral split that showed up when Smart Finance AI examined how weak jobs data pulled the Dow and Nasdaq in opposite directions — one dataset, two completely different portfolio outcomes depending on what you owned.
A Better Frame: Three Moves This Week
Any “undervalued stocks” list circulating now may rest on an August 2024 snapshot. Pull today's forward P/E, dividend yield and 10-year Treasury yield yourself from a primary source before assuming a discount still exists. A valuation is a fact with an expiration date, and re-checking it is the cheapest financial planning step available.
The index de-rated about 9.4% while TSM was cited at 15x versus a historical 20x. The second comparison is the informative one. Screen for companies trading at 5–10 year low multiples with the balance-sheet quality Barron's emphasized during the pullback — consistent cash flow, falling debt, rising shareholder returns. Note who was buying, too: MarketWatch reported institutional accumulation concentrated in healthcare and industrials, while corporate buyback activity picked up as companies treated their own shares as undervalued.
Strategists split on timing: some expected recovery within three to four months on historical patterns, others warned the correction could stretch on if economic data deteriorated. S&P Dow Jones Indices puts the average recovery near four months; the widely cited range is four to six. Since nobody can pick the bottom, a fixed contribution schedule removes the guess. AI investing tools and automated screeners are genuinely useful for the grunt work here — filtering by valuation, flagging debt changes — but they inherit whatever earnings estimates they are fed, which is precisely the assumption most likely to be wrong in a correction.
Frequently Asked Questions
Is a 10% stock market correction a good time to invest?
Historically it has been a reasonable entry point for long-term investors: buyers during the 2018, 2020 and 2022 pullbacks saw average returns of 15–25% over the following 12 months. But that is three episodes from one favorable decade, and it says nothing about any single stock. The more durable takeaway is that a correction changes the price you pay, not the quality of what you own.
How long does it take for the S&P 500 to recover from a correction?
S&P Dow Jones Indices counts 28 corrections of 10% or more since 1950 with an average recovery time of about four months, and commonly cited ranges run four to six months. Averages hide the tails — some recoveries have taken far longer, and forecasters disagreed even during the August 2024 episode about whether it would resolve in three to four months or drag on.
What are the best value stocks to buy during a market downturn?
No article can answer that for an individual investment portfolio, and this one is not attempting to. What the coverage as of August 2024 consistently pointed toward was a profile rather than a ticker: strong balance sheets, consistent cash flow, falling debt, and a multiple meaningfully below the company's own history. Value and dividend-paying companies have historically held up better than growth names through downturns and early recoveries — historically being the operative word.
Bottom line: our read is that the August 2024 correction was mostly a valuation event, not an earnings event — a roughly 9.4% multiple contraction against expected earnings growth of 8–10% — which is why it drew buyers rather than panic. The more useful lesson for anyone tracking the stock market today is structural: the discounts in a correction are concentrated, not distributed, and a list of “undervalued” names loses most of its value the moment its underlying prices go stale. On balance, the process — verifying dates, comparing a company to its own history, buying on a schedule — outlasts any specific three-stock recommendation.
Disclaimer: This article is editorial commentary for informational purposes only and does not constitute financial advice, a recommendation, or an offer to buy or sell any security. No independent product or investment testing was performed; all figures are drawn from the published sources cited above and reflect the dates stated. Market data referenced is historical and may not reflect current prices. Research based on publicly available sources current as of August 13, 2026.